Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-06-06
1992-06-30
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530329, 530330, 530331, C07K 506, A61K 3702
Patent
active
051263262
ABSTRACT:
Disclosed herein are peptide derivatives which inhibit the activities of human immunodeficiency virus (HIV) protease and renin. The peptide derivatives can be represented by general formula R.sup.1 --R.sup.2 --Y--R.sup.3 --R.sup.4 wherein R.sup.1 is a derived amino acid based on an O.sup.4 -(carboxymethyl)-tyrosyl residue, R.sup.2 and are amino acid or analogous amino acid residues (R.sup.3 may optionally be absent), Y is a non-peptide linking unit, e.g. statyl, and R.sup.4 is [--NR.sup.17 CHR.sup.18 --C(O)].sub.p --Z wherein R.sup.17 is hydrogen or lower alkyl, R.sup.18 is an amino acid or analogous amino acid side chain, p is zero or one and Z is a terminal group (e.g. hydroxy or amino), or R.sup.4 is --NR.sup.17 CR.sup.18 (R.sup.21)CH.sub.2 OH wherein R.sup.17 and R.sup.18 are as noted hereinabove and R.sup.21 is hydrogen, lower alkyl or hydroxy(lower)alkyl. The derivatives are useful as agents for combatting HIV infections and for treating renin-associated hypertension and congestive heart failure.
REFERENCES:
Moore et al., Bioch. & Biophys. Res. Comm. 159(2), pp. 420-425 (1989).
Richards et al., FEBS Letters 247(1), pp. 113-116 (1989).
Seelmeier et al., PNAS vol. 854, pp. 6612-6616 (1988).
Anderson Paul C.
Guindon Yvan
Yoakim Christiane
Bio-Mega Inc.
Frankhouser David E.
Gabilan M. S. H.
Ramsuer Robert W.
Reitenbach Daniel
LandOfFree
Enzyme inhibiting peptide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enzyme inhibiting peptide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme inhibiting peptide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1863818